My main research focus is to identify biomarkers that predict response to neoadjuvant chemotherapy in breast cancer patients. Different chemotherapeutic agents seem to induce different kind of cell deaths. This is a further, very interesting research field since new, targeted immunotherapy concepts may differ in their compatibility with chemotherapy.
Techniques, methods & infrastructure
ELISA techniques to identify biomarkers in patients blood samples
Cellculture assays using breast cancer tumor cells in co-culture with human white blood cells
FACS analysis for determing different kinds of cell deaths induced by various chemotherapeutic agents